Modulation of ORAI2 and ORAI3 Calcium Channels
Modulation of ORAI2 and ORAI3 Calcium Channels
批准号:
9181053
负责人:
STEFAN FESKE
金额:
$25.43万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2018-06-30
关键词:
AccountingAffinityAnimal ModelAntibodiesAntibody AffinityArachidonic AcidsAutoimmunityBindingCRISPR/Cas technologyCalciumCalcium ChannelCell membraneCell physiologyCellsCellular ImmunityCerebellumChemicalsColitisCollaborationsComplexDataDetectionDisabled PersonsDiseaseDrug TargetingFamilyGene DeletionGenerationsGenesGoalsGrowthHealthHippocampus (Brain)Histocompatibility TestingHomologous GeneHumanImmuneImmune System DiseasesImmune responseImmunologic Deficiency SyndromesIn VitroIndividualInfectionInflammationKnock-outKnockout MiceKnowledgeLeukotriene C4LifeLiteratureLymphocyteLymphocyte FunctionMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of prostateMediatingMembraneMembrane ProteinsMessenger RNAMethodsMonoclonal AntibodiesMusMutationNerve DegenerationOrganPathologyPatientsPharmaceutical PreparationsPhysiologicalPre-Clinical ModelProcessProductionPropertyProtein IsoformsProteinsRNA InterferenceReagentRegulationReporterResearchRoleSTIM1 geneSolidSurfaceT-LymphocyteTechnologyTestingTherapeuticTissuesTransgenic Miceabstractingbasebrain cellcancer cellcell typecytokinegraft vs host diseasehandicapping conditionimmune functionimmunogenicityin vivoinhibitor/antagonistinsightmalignant breast neoplasmmembermouse modelneonatal Fc receptornull mutationoverexpressionresponsesuccesstherapeutic developmenttooltumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary / Abstract
The goal of this proposal is to understand the contribution of ORAI calcium channels to cell and tissue function
in health and disease. Each of the 3 ORAI proteins (ORAI1, 2, 3) forms a calcium channel when
overexpressed in cells. ORAI1 is the best characterized of these and encodes the calcium release-activated
calcium (CRAC). Patients with null mutations in ORAI1 suffer from severe immunodeficiency due to impaired
calcium influx in immune cells. Using ORAI1 deficient mice, we found that ORAI1 is essential for lymphocyte
function and immune responses in vivo and inhibition of ORAI1 protects mice from T cell mediated
autoimmunity. In contrast to ORAI1, the roles of ORAI2 and ORAI3 in vivo are largely unknown and it is
unclear if endogenously expressed ORAI2 and ORAI3 contribute to the function of immune or non-immune
cells. This knowledge gap is in large part due to a lack of specific reagents including Orai2 and Orai3 knockout
mice and high affinity antibodies to analyze the function and expression of ORAI proteins in health and
disease. ORAI3 was shown to mediate calcium influx in certain cancer cells and to promote their growth and
invasiveness. These findings are intriguing, but need to be corroborated using knockout mice for in vivo
studies. Almost nothing is known about the role of ORAI2 in vivo. Using new Orai2-deficient reporter mice, we
found expression of ORAI2 in many immune cells and the brain. In immune cells, lack of ORAI2 alone does not
impair calcium influx, but its deletion together with ORAI1 abolishes calcium influx and severely impairs T cell-
mediated immunity. This cooperative role of ORAI1 and ORAI2 raises the possibility that both homologs can
form heteromeric channels in immune cells and potentially other cell types. To understand the physiological
and pathophysiological roles of endogenous ORAI1, 2 and 3 channels in vivo we need conditional knockout
mice that allow tissue and cell type-specific deletion of single or multiple Orai genes. We propose to generate
conditional Orai2 and Orai3 knockout mice and to cross these to each other and Orai1-deficient mice to
generate double and triple knockout mice to investigate the function of individual ORAI proteins and their
synergistic roles in tissues in vivo. Conditional deletion is essential as complete deletion of Orai1 is lethal and
its combined deletion with other Orai genes would therefore be lethal, too. Research on ORAI channels is
severely handicapped by a lack of specific antibodies for the detection of ORAI proteins in live cells to test their
expression, subcellular localization and function. We recently generated antibodies against ORAI1 that not only
detect ORAI1 in live cells but also inhibit calcium influx. We propose to develop specific antibodies against
ORAI2 and ORAI3 to study their expression in healthy and diseased tissues and to inhibit their function. These
new tools will be shared with other labs and will provide important new insight into the physiological and
pathological roles of ORAI channels, with the goal of creating rationales for the development of therapeutic
ORAI channel inhibitors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:10153457
-
项目类别:
-
资助金额:$53.17万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:9980846
-
项目类别:
-
资助金额:$53.41万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:10626980
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Ca2+ signaling via SOCE in the pathogenesis of Sjögren’s syndrome
-
批准号:10392382
-
项目类别:
-
资助金额:$52.71万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Calcium channel CACNB1 in T cell function and immunity
-
批准号:9811165
-
项目类别:
-
资助金额:$16.95万
-
财政年份:2019
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of encephalitogenic T cells by CRAC channels
-
批准号:10461826
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2018
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of encephalitogenic T cells by CRAC channels
-
批准号:9981624
-
项目类别:
-
资助金额:$48.27万
-
财政年份:2018
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of encephalitogenic T cells by CRAC channels
-
批准号:10238856
-
项目类别:
-
资助金额:$48.87万
-
财政年份:2018
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of Follicular T cell Responses in the Lung by Ion Channels
-
批准号:9765152
-
项目类别:
-
资助金额:$47.46万
-
财政年份:2017
-
负责人:STEFAN FESKE
-
依托单位:
Regulation of Follicular T cell Responses in the Lung by Ion Channels
-
批准号:9444252
-
项目类别:
-
资助金额:$50.55万
-
财政年份:2017
-
负责人:STEFAN FESKE
-
依托单位:
Identifying Novel Ion Channels Regulating T cell Function
-
批准号:9297218
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
Identifying Novel Ion Channels Regulating T cell Function
-
批准号:9165869
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
FASEB SRC on Calcium and Cell Function
-
批准号:9121418
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2016
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:8820394
-
项目类别:
-
资助金额:$8.95万
-
财政年份:2014
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:8664577
-
项目类别:
-
资助金额:$45.69万
-
财政年份:2013
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:8659340
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:9918240
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:9063465
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:10395936
-
项目类别:
-
资助金额:$54.13万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
CRAC Channel Deficiency in Immunity to Infection
-
批准号:9602202
-
项目类别:
-
资助金额:$53.62万
-
财政年份:2012
-
负责人:STEFAN FESKE
-
依托单位:
海外基金